Forty patients with pulmonary aspergilloma admitted to Juntendo University Hospital from 1960 to 1988 and 26 cases referred for serologic diangosis from other institutes were subjected to analysis of thier clinical features, treatment and prognosis.
The age at diagnosis ranged from 31 to 81 years (mean: 61 years). There were 55 men and 11 women. The most common preceding lung lesion was an open healed tuberculous cavity, which was present in 30 patients (45.5%). Other lesions included lung abscess in 5 patients (7.6%), lung cyst in 3 (4.5%) and unknown in 28 (42.4%). Aspergilloma occurred with equal frequency in each lung (right: 31; left: 31). In 63 cases aspergilloma was situated in an upper lobe, while one was in the left lower lobe and two were in the right upper and lower lobes. Sixty patients (90.9%) had one aspergilloma, 5 had two aspergillomas (7.6%) and 3 had three aspergillomas (4.5%).
Sputum samples were obtained from 40 patients, and
Aspergillus fumigatus was cultured from 21 patients (52.5%).
A. flavus and
A. candidus were each cultured from one patient. In 7 cases, the culutred
Aspergillus could not be completely identified, and the culture was negative for 10 patients.
Roentogenographically, the period of formation of the pulmonary aspergilloma ranged from 5.5 months to 12 years (mean: 4 years and 6 months).
The treatment of our 40 original patients varied, with only one patient undergoing surgery and 27 patients administered antifungal agents. Inhaled and systemic antifungal agents were ineffective even after several weeks of usage. Antifungal drugs were instilled directly into the cavity in 15 patients, . by either percutaneous puncture (1 patient) or endobronchial instillation using a flexible bronchocatheter (14 patients). The antifungal drugs used for endobronchial instillation were amphotericin B (8 patients), flucytosine (2 patients), miconazole (3 patietns), clotrimazole (1 patient) and fluconazole (1 patietn). In 4 patients, a single attempt at endobronchial instillation failed. Of 8 patients in whom instillation of antifungal drugs by the endobronchial route was repeated, four aspergillomas disappeared within a few months (2 patients received amphotericin B, 1 patient flucytosine and 1 patient miconazole). One patient expectorated fragments, and the fungus ball disappeared during the course of complicated pyogenic infection of the cavity. Spontaneous lysis of the aspergilloma occurred in three patients (7.5%).
Of our 40 cases, 13 patients died from respiratory diseases (6: pneumonia, probably bacterial pneumonia; 5: chronic respiratory failure; and 2: hemoptysis), while 5 patients died from other underlying diseases.
Hemoptysis occurred in over half the patients, but fatal hemoptysis occurred in two of our patients. This incidence is lower than in earlier reports.
In conclusion, endobronchial instillation of antifungal drugs was useful for the treatment of pulmonary aspergilloma in patients unfit for surgery.
View full abstract